Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound.
Korting
H C
HC
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, BRD.
D000279:Administration, Cutaneous; D000328:Adult; D001284:Atrophy; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000009:adverse effects; D002990:Clobetasol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D004311:Double-Blind Method; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D014677:Pharmaceutical Vehicles; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D012867:Skin / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D014463:Ultrasonography
D005938:Glucocorticoids; D014677:Pharmaceutical Vehicles; C063919:hydrocortisone aceponate; D001624:Betamethasone Valerate; D011239:Prednisolone; D002990:Clobetasol; C035287:prednicarbate; D006854:Hydrocortisone